Boehringer Ingelheim

Boehringer Ingelheim is a prominent pharmaceutical company dedicated to developing innovative healthcare products for both human and animal health. As a research-driven organization, it focuses on the research, development, manufacturing, and marketing of pharmaceuticals that aim to enhance health and improve quality of life. The company's commitment to advancing medical science is reflected in its extensive portfolio of treatments and its efforts to address unmet medical needs across various therapeutic areas. Boehringer Ingelheim is recognized for its contributions to healthcare, emphasizing the importance of innovation and quality in its product offerings.

Anjan Chatterjee

Corporate Vice President

Kanad Das

Investment Director, Boehringer Ingelheim Venture Fund

Christian Eckermann

SVP, Head of Biopharma Austria

Martin Heidecker

Managing Director

Frank Kalkbrenner

Director, Investment Manager

Debbie Lin

Executive Director

Oliver Reuss

Executive Director and Investment Manager

Arun Thachi

Director, IT Omnichannel Ecosystem Evolution

Clive Wood

Senior Vice President

Past deals in Pets

Saiba Animal Health

Acquisition in 2024
Saiba Animal Health is a biotechnology company dedicated to developing innovative therapeutic drugs and vaccines aimed at treating chronic diseases in dogs. The firm utilizes a recombinant virus-like particle vaccine platform designed to induce long-lasting antibodies that specifically target key molecules associated with various chronic conditions. By focusing on the treatment of allergies, inflammation, pain, nervous system disorders, and cancer, Saiba Animal Health aims to enhance the well-being and quality of life for both pets and their owners.

Otto

Series B in 2023
Otto provides an integrated mobile app extension to existing veterinarian practice management systems. The Otto app allows two-way communication between clients and veterinary staff, enabling telemedicine, appointment scheduling, digital prescriptions and much more.

Ruipeng Pet Healthcare

Venture Round in 2020
Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator, which covers pet healthcare, foster care, bathing, SPA, beauty, food, entertainment and leisure services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.